Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis—Brief Report | Zendy

Mehdi Afshar | Zendy; Pia R. Kamstrup | Zendy; Ken Williams | Zendy; Allan D. Sniderman | Zendy; Børge G. Nordestgaard | Zendy; George Thanassoulis | Zendy

Open Access

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis—Brief Report

Author(s) -

Mehdi Afshar,

Pia R. Kamstrup,

Ken Williams,

Allan D. Sniderman,

Børge G. Nordestgaard,

George Thanassoulis

Publication year - 2016

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.116.308271

Subject(s) - attributable risk , medicine , population , relative risk , risk factor , lipoprotein(a) , myocardial infarction , confidence interval , absolute risk reduction , dyslipidemia , cardiology , epidemiology , lipoprotein , cholesterol , obesity , environmental health

High lipoprotein(a) (Lp[a]) is the most common genetic dyslipidemia and is a causal factor for myocardial infarction (MI) and aortic stenosis (AS). We sought to estimate the population impact of Lp(a) lowering that could be achieved in primary prevention using the therapies in development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research